Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
Add more filters










Publication year range
1.
Cell ; 186(5): 1013-1025.e24, 2023 03 02.
Article in English | MEDLINE | ID: mdl-36827973

ABSTRACT

The emergence of drug-resistant tuberculosis has created an urgent need for new anti-tubercular agents. Here, we report the discovery of a series of macrolides called sequanamycins with outstanding in vitro and in vivo activity against Mycobacterium tuberculosis (Mtb). Sequanamycins are bacterial ribosome inhibitors that interact with the ribosome in a similar manner to classic macrolides like erythromycin and clarithromycin, but with binding characteristics that allow them to overcome the inherent macrolide resistance of Mtb. Structures of the ribosome with bound inhibitors were used to optimize sequanamycin to produce the advanced lead compound SEQ-9. SEQ-9 was efficacious in mouse models of acute and chronic TB as a single agent, and it demonstrated bactericidal activity in a murine TB infection model in combination with other TB drugs. These results support further investigation of this series as TB clinical candidates, with the potential for use in new regimens against drug-susceptible and drug-resistant TB.


Subject(s)
Antitubercular Agents , Mycobacterium tuberculosis , Animals , Mice , Antitubercular Agents/pharmacology , Macrolides , Drug Resistance, Bacterial , Clarithromycin
2.
Cancer Res Commun ; 2(11): 1504-1519, 2022 11.
Article in English | MEDLINE | ID: mdl-36970050

ABSTRACT

The receptor tyrosine kinase VEGFR-3 plays a crucial role in cancer-induced angiogenesis and lymphangiogenesis, promoting tumor development and metastasis. Here, we report the novel VEGFR-3 inhibitor EVT801 that presents a more selective and less toxic profile than two major inhibitors of VEGFRs (i.e., sorafenib and pazopanib). As monotherapy, EVT801 showed a potent antitumor effect in VEGFR-3-positive tumors, and in tumors with VEGFR-3-positive microenvironments. EVT801 suppressed VEGF-C-induced human endothelial cell proliferation in vitro and tumor (lymph)angiogenesis in different tumor mouse models. In addition to reduced tumor growth, EVT801 decreased tumor hypoxia, favored sustained tumor blood vessel homogenization (i.e., leaving fewer and overall larger vessels), and reduced important immunosuppressive cytokines (CCL4, CCL5) and myeloid-derived suppressor cells (MDSC) in circulation. Furthermore, in carcinoma mouse models, the combination of EVT801 with immune checkpoint therapy (ICT) yielded superior outcomes to either single treatment. Moreover, tumor growth inhibition was inversely correlated with levels of CCL4, CCL5, and MDSCs after treatment with EVT801, either alone or combined with ICT. Taken together, EVT801 represents a promising anti(lymph)angiogenic drug for improving ICT response rates in patients with VEGFR-3 positive tumors. Significance: The VEGFR-3 inhibitor EVT801 demonstrates superior selectivity and toxicity profile than other VEGFR-3 tyrosine kinase inhibitors. EVT801 showed potent antitumor effects in VEGFR-3-positive tumors, and tumors with VEGFR-3-positive microenvironments through blood vessel homogenization, and reduction of tumor hypoxia and limited immunosuppression. EVT801 increases immune checkpoint inhibitors' antitumor effects.


Subject(s)
Neoplasms , Vascular Endothelial Growth Factor Receptor-3 , Humans , Mice , Animals , Vascular Endothelial Growth Factor Receptor-3/therapeutic use , Neovascularization, Pathologic/drug therapy , Neoplasms/drug therapy , Angiogenesis Inhibitors/pharmacology , Protein Kinase Inhibitors/therapeutic use , Immunotherapy , Tumor Microenvironment
3.
Environ Sci Technol ; 55(11): 7571-7582, 2021 06 01.
Article in English | MEDLINE | ID: mdl-33983016

ABSTRACT

Life cycle assessments (LCAs) quantify environmental impacts of systems and support decision-making processes. LCAs are however time-consuming and difficult to conduct for nonexperts, thus calling for simplified approaches for multicriteria environmental assessments. In this paper, a five-step protocol is presented to generate simplified arithmetic equations from a reference parametrized LCA model of an energy system and its application illustrated for an enhanced geothermal system for heat generation with very low direct emissions in continental Europe. The simplified models estimate seven environmental impacts (climate change, freshwater ecotoxicity, human health, minerals and metals, and fossil resources depletion, and acidification) based on six technological parameters: number of injection and production wells, power of the production and injection pump, average well length, thermal power output, and eight background parameters defining the European electricity mix. A global sensitivity analysis identified these parameters as influencing the variance of the environmental impacts the most. Ensuring the representativeness of the reference LCA model and the validity of the simplified models requires thorough assessment. This protocol allows to develop relevant alternatives to detailed LCAs for quick and multicriteria environmental impact assessments of energy systems, showing that LCAs can be simplified to system-specific equations based on few, easily quantified, parameters.


Subject(s)
Electricity , Environment , Animals , Europe , Humans , Life Cycle Stages , Thermogenesis
4.
mBio ; 10(4)2019 07 09.
Article in English | MEDLINE | ID: mdl-31289182

ABSTRACT

A defining characteristic of treating tuberculosis is the need for prolonged administration of multiple drugs. This may be due in part to subpopulations of slowly replicating or nonreplicating Mycobacterium tuberculosis bacilli exhibiting phenotypic tolerance to most antibiotics in the standard treatment regimen. Confounding this problem is the increasing incidence of heritable multidrug-resistant M. tuberculosis A search for new antimycobacterial chemical scaffolds that can kill phenotypically drug-tolerant mycobacteria uncovered tricyclic 4-hydroxyquinolines and a barbituric acid derivative with mycobactericidal activity against both replicating and nonreplicating M. tuberculosis Both families of compounds depleted M. tuberculosis of intrabacterial magnesium. Complete or partial resistance to both chemotypes arose from mutations in the putative mycobacterial Mg2+/Co2+ ion channel, CorA. Excess extracellular Mg2+, but not other divalent cations, diminished the compounds' cidality against replicating M. tuberculosis These findings establish depletion of intrabacterial magnesium as an antimicrobial mechanism of action and show that M. tuberculosis magnesium homeostasis is vulnerable to disruption by structurally diverse, nonchelating, drug-like compounds.IMPORTANCE Antimycobacterial agents might shorten the course of treatment by reducing the number of phenotypically tolerant bacteria if they could kill M. tuberculosis in diverse metabolic states. Here we report two chemically disparate classes of agents that kill M. tuberculosis both when it is replicating and when it is not. Under replicating conditions, the tricyclic 4-hydroxyquinolines and a barbituric acid analogue deplete intrabacterial magnesium as a mechanism of action, and for both compounds, mutations in CorA, a putative Mg2+/Co2+ transporter, conferred resistance to the compounds when M. tuberculosis was under replicating conditions but not under nonreplicating conditions, illustrating that a given compound can kill M. tuberculosis in different metabolic states by disparate mechanisms. Targeting magnesium metallostasis represents a previously undescribed antimycobacterial mode of action that might cripple M. tuberculosis in a Mg2+-deficient intraphagosomal environment of macrophages.


Subject(s)
Antitubercular Agents/pharmacology , Cation Transport Proteins/genetics , Magnesium/metabolism , Mycobacterium tuberculosis/drug effects , Mycobacterium tuberculosis/genetics , DNA Replication , Homeostasis , Mutation
5.
Science ; 363(6426)2019 02 01.
Article in English | MEDLINE | ID: mdl-30705156

ABSTRACT

Mycobacterium tuberculosis (Mtb) is the leading infectious cause of death in humans. Synthesis of lipids critical for Mtb's cell wall and virulence depends on phosphopantetheinyl transferase (PptT), an enzyme that transfers 4'-phosphopantetheine (Ppt) from coenzyme A (CoA) to diverse acyl carrier proteins. We identified a compound that kills Mtb by binding and partially inhibiting PptT. Killing of Mtb by the compound is potentiated by another enzyme encoded in the same operon, Ppt hydrolase (PptH), that undoes the PptT reaction. Thus, loss-of-function mutants of PptH displayed antimicrobial resistance. Our PptT-inhibitor cocrystal structure may aid further development of antimycobacterial agents against this long-sought target. The opposing reactions of PptT and PptH uncover a regulatory pathway in CoA physiology.


Subject(s)
Bacterial Proteins/antagonists & inhibitors , Coenzyme A/metabolism , Guanidine/analogs & derivatives , Hydrolases/antagonists & inhibitors , Mycobacterium tuberculosis/enzymology , Transferases (Other Substituted Phosphate Groups)/antagonists & inhibitors , Urea/analogs & derivatives , Acyl Carrier Protein/metabolism , Animals , Catalytic Domain , Drug Resistance, Bacterial/genetics , Female , Guanidine/pharmacology , Hydrolases/genetics , Lipid Metabolism , Loss of Function Mutation , Mice , Mice, Inbred BALB C , Mycobacterium tuberculosis/genetics , Operon , Protein Binding , Protein Structure, Tertiary , Small Molecule Libraries , Urea/pharmacology
6.
Sci Total Environ ; 578: 268-280, 2017 Feb 01.
Article in English | MEDLINE | ID: mdl-27836349

ABSTRACT

In the life cycle assessment (LCA) context, global sensitivity analysis (GSA) has been identified by several authors as a relevant practice to enhance the understanding of the model's structure and ensure reliability and credibility of the LCA results. GSA allows establishing a ranking among the input parameters, according to their influence on the variability of the output. Such feature is of high interest in particular when aiming at defining parameterized LCA models. When performing a GSA, the description of the variability of each input parameter may affect the results. This aspect is critical when studying new products or emerging technologies, where data regarding the model inputs are very uncertain and may cause misleading GSA outcomes, such as inappropriate input rankings. A systematic assessment of this sensitivity issue is now proposed. We develop a methodology to analyze the sensitivity of the GSA results (i.e. the stability of the ranking of the inputs) with respect to the description of such inputs of the model (i.e. the definition of their inherent variability). With this research, we aim at enriching the debate on the application of GSA to LCAs affected by high uncertainties. We illustrate its application with a case study, aiming at the elaboration of a simple model expressing the life cycle greenhouse gas emissions of enhanced geothermal systems (EGS) as a function of few key parameters. Our methodology allows identifying the key inputs of the LCA model, taking into account the uncertainty related to their description.

7.
Cancers (Basel) ; 6(1): 472-90, 2014 Feb 28.
Article in English | MEDLINE | ID: mdl-24589997

ABSTRACT

Myeloid derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs) represent prominent components in cancer progression. We previously showed that inhibition of the VEGFR-3 pathway by SAR131675 leads to reduction of TAM infiltration and tumor growth. Here, we found that treatment with SAR131675 prevents the accumulation of immunosuppressive blood and splenic MDSCs which express VEGFR-3, in 4T1 tumor bearing mice. Moreover we showed that soluble factors secreted by tumor cells promote MDSCs proliferation and differentiation into M2 polarized F4/80+ macrophages. In addition, cell sorting and transcriptomic analysis of tumor infiltrating myeloid cells revealed the presence of a heterogeneous population that could be divided into 3 subpopulations: (i) immature cells with a MDSC phenotype (GR1+/CD11b+/F4/80-); (ii) "immuno-incompetent" macrophages (F4/80high/CD86neg/MHCIILow) strongly expressing M2 markers such as Legumain, CD206 and Mgl1/2 and (iii) "immuno-competent"-M1 like macrophages (F4/80Low/CD86+/MHCIIHigh). SAR131675 treatment reduced MDSCs in lymphoid organs as well as F4/80High populations in tumors. Interestingly, in the tumor SAR131675 was able to increase the immunocompetent M1 like population (F4/80low). Altogether these results demonstrate that the specific VEGFR-3 inhibitor SAR131675 exerts its anti tumoral activity by acting on different players that orchestrate immunosuppression and cancer progression in a tumoral context: MDSCs in peripheral lymphoid organs and TAMs infiltrating the tumor.

8.
Cancer Cell ; 23(4): 477-88, 2013 Apr 15.
Article in English | MEDLINE | ID: mdl-23597562

ABSTRACT

Receptor tyrosine kinases (RTK) are targets for anticancer drug development. To date, only RTK inhibitors that block orthosteric binding of ligands and substrates have been developed. Here, we report the pharmacologic characterization of the chemical SSR128129E (SSR), which inhibits fibroblast growth factor receptor (FGFR) signaling by binding to the extracellular FGFR domain without affecting orthosteric FGF binding. SSR exhibits allosteric properties, including probe dependence, signaling bias, and ceiling effects. Inhibition by SSR is highly conserved throughout the animal kingdom. Oral delivery of SSR inhibits arthritis and tumors that are relatively refractory to anti-vascular endothelial growth factor receptor-2 antibodies. Thus, orally-active extracellularly acting small-molecule modulators of RTKs with allosteric properties can be developed and may offer opportunities to improve anticancer treatment.


Subject(s)
Protein Kinase Inhibitors/pharmacology , Receptors, Fibroblast Growth Factor/antagonists & inhibitors , Receptors, Fibroblast Growth Factor/metabolism , Small Molecule Libraries/pharmacology , Allosteric Regulation , Animals , Antibodies, Monoclonal/pharmacology , Arthritis, Experimental/drug therapy , Bone Resorption/drug therapy , Carcinoma, Lewis Lung/drug therapy , Carcinoma, Lewis Lung/metabolism , Carcinoma, Lewis Lung/pathology , Fibroblast Growth Factors/antagonists & inhibitors , Fibroblast Growth Factors/metabolism , HEK293 Cells , Human Umbilical Vein Endothelial Cells/cytology , Human Umbilical Vein Endothelial Cells/drug effects , Human Umbilical Vein Endothelial Cells/metabolism , Humans , Mice , Neovascularization, Pathologic/drug therapy , Pancreatic Neoplasms/drug therapy , Pancreatic Neoplasms/metabolism , Pancreatic Neoplasms/pathology , Phosphorylation/drug effects , Protein Kinase Inhibitors/metabolism , Receptor Protein-Tyrosine Kinases/antagonists & inhibitors , Signal Transduction , Xenograft Model Antitumor Assays
9.
Environ Sci Technol ; 47(3): 1231-8, 2013 Feb 05.
Article in English | MEDLINE | ID: mdl-23259663

ABSTRACT

This study presents a generic methodology to produce simplified models able to provide a comprehensive life cycle impact assessment of energy pathways. The methodology relies on the application of global sensitivity analysis to identify key parameters explaining the impact variability of systems over their life cycle. Simplified models are built upon the identification of such key parameters. The methodology is applied to one energy pathway: onshore wind turbines of medium size considering a large sample of possible configurations representative of European conditions. Among several technological, geographical, and methodological parameters, we identified the turbine load factor and the wind turbine lifetime as the most influent parameters. Greenhouse Gas (GHG) performances have been plotted as a function of these key parameters identified. Using these curves, GHG performances of a specific wind turbine can be estimated, thus avoiding the undertaking of an extensive Life Cycle Assessment (LCA). This methodology should be useful for decisions makers, providing them a robust but simple support tool for assessing the environmental performance of energy systems.


Subject(s)
Electricity , Energy-Generating Resources , Models, Theoretical , Wind , Europe , Greenhouse Effect , Probability
10.
Mol Cancer Ther ; 11(8): 1637-49, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22584122

ABSTRACT

SAR131675 is a potent and selective VEGFR-3 inhibitor. It inhibited VEGFR-3 tyrosine kinase activity and VEGFR-3 autophosphorylation in HEK cells with IC(50) values of 20 and 45 nmol/L, respectively. SAR131675 dose dependently inhibited the proliferation of primary human lymphatic cells, induced by the VEGFR-3 ligands VEGFC and VEGFD, with an IC(50) of about 20 nmol/L. SAR131675 was found to be highly selective for VEGFR-3 versus 107 receptors, enzymes, ion channels, and 65 kinases. However, it was moderately active on VEGFR-2 with a VEGFR-3/VEGFR-2 ratio of about 10. SAR131675 had no antiproliferative activity on a panel of 30 tumors and primary cells, further showing its high specificity and indicating that SAR131675 is not a cytotoxic or cytostatic agent. SAR131675 was very well tolerated in mice and showed a potent antitumoral effect in several orthotopic and syngenic models, including mammary 4T1 carcinoma and RIP1.Tag2 tumors. Interestingly, it significantly reduced lymph node invasion and lung metastasis, showing its antilymphangiogenic activity in vivo. Moreover, treatment of mice before resection of 4T1 primary tumors was sufficient to prevent metastasis. Tumor-associated macrophages (TAM) play an important role in tumor growth and metastasis. The expression of VEGFR-3 on TAMs has been recently described. F4/80 immunostaining clearly showed that SAR131675 significantly reduced TAM infiltration and aggregation in 4T1 tumors. Taken together, SAR131675 is the first highly specific VEGFR-3-TK inhibitor described to date, displaying significant antitumoral and antimetastatic activities in vivo through inhibition of lymphangiogenesis and TAM invasion.


Subject(s)
Angiogenesis Inhibitors/pharmacology , Antineoplastic Agents/pharmacology , Naphthyridines/pharmacology , Protein Kinase Inhibitors/pharmacology , Vascular Endothelial Growth Factor Receptor-3/antagonists & inhibitors , Angiogenesis Inhibitors/administration & dosage , Animals , Antineoplastic Agents/administration & dosage , Cell Movement/drug effects , Cell Survival/drug effects , Cell Transformation, Neoplastic/drug effects , Enzyme Activation/drug effects , Female , Humans , Lymphangiogenesis/drug effects , Lymphocytes/drug effects , Lymphocytes/metabolism , Macrophages/drug effects , Mammary Neoplasms, Experimental/drug therapy , Mammary Neoplasms, Experimental/metabolism , Mammary Neoplasms, Experimental/pathology , Mice , Mice, Transgenic , Naphthyridines/administration & dosage , Neoplasm Metastasis , Neovascularization, Physiologic/drug effects , Protein Kinase Inhibitors/administration & dosage , Tumor Burden/drug effects , Vascular Endothelial Growth Factor Receptor-1/antagonists & inhibitors , Vascular Endothelial Growth Factor Receptor-2/antagonists & inhibitors , Xenograft Model Antitumor Assays , Zebrafish
11.
PLoS One ; 2(9): e851, 2007 Sep 05.
Article in English | MEDLINE | ID: mdl-17786222

ABSTRACT

BACKGROUND: Pathological accumulation of cholesterol in late endosomes is observed in lysosomal storage diseases such as Niemann-Pick type C. We here analyzed the effects of cholesterol accumulation in NPC cells, or as phenocopied by the drug U18666A, on late endosomes membrane organization and dynamics. METHODOLOGY/PRINCIPAL FINDINGS: Cholesterol accumulation did not lead to an increase in the raft to non-raft membrane ratio as anticipated. Strikingly, we observed a 2-3 fold increase in the size of the compartment. Most importantly, properties and dynamics of late endosomal intralumenal vesicles were altered as revealed by reduced late endosomal vacuolation induced by the mutant pore-forming toxin ASSP, reduced intoxication by the anthrax lethal toxin and inhibition of infection by the Vesicular Stomatitis Virus. CONCLUSIONS/SIGNIFICANCE: These results suggest that back fusion of intralumenal vesicles with the limiting membrane of late endosomes is dramatically perturbed upon cholesterol accumulation.


Subject(s)
Cholesterol/metabolism , Endosomes/metabolism , Animals , CHO Cells , Cell Compartmentation , Cricetinae , Cricetulus , Phospholipids/metabolism , Protein Transport
12.
Redox Rep ; 12(1): 96-100, 2007.
Article in English | MEDLINE | ID: mdl-17263919

ABSTRACT

The platelet-derived growth factor receptor-beta (PDGFRbeta) signaling pathway regulates smooth muscle cell (SMC) migration and proliferation in the vascular wall. Oxidized low-density lipoproteins (oxLDLs) and 4-hydroxynonenal (4-HNE) induce a dual effect on PDGFRbeta signaling. Short-term incubation of SMCs with oxLDLs and 4-HNE induced PDGFRbeta activation. Long-term incubation triggered a desensitization of PDGFR to its own agonist, with a progressive inhibition of PDGFRbeta phosphorylation, associated with increased formation of HNE-PDGFR adducts in SMC and in vivo, in the aortae of apoE-deficient mice. Hydralazine used as carbonyl scavenger prevented PDGFRbeta inhibition in vitro and in vivo In conclusion, PDGFRbeta is a target for 4-HNE, acrolein and oxidative stress and its progressive inhibition may contribute to defective SMC proliferation and decrease the stability of a vulnerable plaque.


Subject(s)
Atherosclerosis/physiopathology , Lipid Peroxidation/physiology , Lipoproteins, LDL/physiology , Muscle, Smooth, Vascular/physiopathology , Receptor, Platelet-Derived Growth Factor beta/physiology , Acrolein/toxicity , Aldehydes/toxicity , Animals , Oxidative Stress/drug effects , Oxidative Stress/physiology , Phosphorylation , Receptor, Platelet-Derived Growth Factor beta/metabolism
13.
Nature ; 444(7116): 171-8, 2006 Nov 09.
Article in English | MEDLINE | ID: mdl-17086204

ABSTRACT

The duplication of entire genomes has long been recognized as having great potential for evolutionary novelties, but the mechanisms underlying their resolution through gene loss are poorly understood. Here we show that in the unicellular eukaryote Paramecium tetraurelia, a ciliate, most of the nearly 40,000 genes arose through at least three successive whole-genome duplications. Phylogenetic analysis indicates that the most recent duplication coincides with an explosion of speciation events that gave rise to the P. aurelia complex of 15 sibling species. We observed that gene loss occurs over a long timescale, not as an initial massive event. Genes from the same metabolic pathway or protein complex have common patterns of gene loss, and highly expressed genes are over-retained after all duplications. The conclusion of this analysis is that many genes are maintained after whole-genome duplication not because of functional innovation but because of gene dosage constraints.


Subject(s)
Evolution, Molecular , Gene Duplication , Genome, Protozoan/genetics , Genomics , Paramecium tetraurelia/genetics , Animals , Eukaryotic Cells/metabolism , Genes, Duplicate/genetics , Genes, Protozoan/genetics , Molecular Sequence Data , Phylogeny
14.
Circ Res ; 98(6): 785-92, 2006 Mar 31.
Article in English | MEDLINE | ID: mdl-16527993

ABSTRACT

The platelet-derived growth factor receptor-beta (PDGFRbeta) signaling pathway regulates smooth muscle cell (SMC) migration and proliferation and plays a role in the vascular wall response to injury. Oxidized low-density lipoprotein (oxLDL) in atherosclerotic lesions can activate the PDGFRbeta pathway, but the long-term effects of oxLDL on PDGFRbeta function are not well understood. We found that oxLDL induced a dual effect on PDGFRbeta signaling. Initial activation of the PDGFR was followed by desensitization of the receptor. PDGFRbeta desensitization was not attributable to PDGFRbeta degradation or changes in localization to the caveolae but instead resulted from decreased PDGF binding and inhibition of PDGFRbeta tyrosine kinase activity. This inhibition was associated with formation of (4HNE)- and acrolein-PDGFRbeta adducts and was mimicked by preincubation of cells with 4HNE. These PDGFRbeta adducts were also detected in aortae of apolipoprotein-deficient mice and hypercholesterolemic rabbits and in human carotid plaques. The aldehyde scavengers DNPH and Hydralazine prevented both oxLDL- and 4HNE-induced structural modification and PDGFRbeta signaling dysfunction in cells and in vivo. OxLDL inhibition of PDGF signaling may contribute to defective SMC proliferation and decrease the stability of a vulnerable plaque.


Subject(s)
Atherosclerosis/metabolism , Hydralazine/pharmacology , Hydrazines/pharmacology , Lipoproteins, LDL/pharmacology , Muscle, Smooth, Vascular/drug effects , Myocytes, Smooth Muscle/drug effects , Receptor, Platelet-Derived Growth Factor beta/drug effects , Aldehydes/metabolism , Aldehydes/pharmacology , Animals , Cells, Cultured , DNA/biosynthesis , Male , Mice , Mice, Transgenic , Muscle, Smooth, Vascular/cytology , Muscle, Smooth, Vascular/metabolism , Myocytes, Smooth Muscle/metabolism , Platelet-Derived Growth Factor/antagonists & inhibitors , Platelet-Derived Growth Factor/metabolism , Rabbits , Receptor, Platelet-Derived Growth Factor beta/physiology , Signal Transduction/physiology
15.
J Virol ; 79(17): 11403-11, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16103191

ABSTRACT

The flavivirus nonstructural protein NS1 is expressed as three discrete species in infected mammalian cells: an intracellular, membrane-associated form essential for viral replication, a cell surface-associated form that may be involved in signal transduction, and a secreted form (sNS1), the biological properties of which remain elusive. To determine the distribution of the dengue virus (DEN) sNS1 protein in vivo, we have analyzed by immunohistological means the tissue tropism of purified DEN sNS1 injected intravenously into adult mice. The sNS1 protein was found predominantly associated with the liver, where hepatocytes appeared to represent a major target cell. We further showed that sNS1 could be efficiently endocytosed by human Huh7 and HepG2 hepatocytes in vitro. After its internalization, the protein was detected intracellularly for at least 48 h without being substantially degraded. Colocalization studies of sNS1 with markers of the endolysosomal compartments revealed that the protein was specifically targeted to lysobisphosphatidic acid-rich structures reminiscent of late endosomes, as confirmed by electron microscopy. Intracellular accumulation of sNS1 in Huh7 cells enhanced the fluid phase uptake of rhodamine-labeled dextran. Furthermore, preincubation of Huh7 cells with sNS1 increased dengue virus production after infection with the homologous strain of DEN-1 virus. Our results demonstrate that the accumulation of DEN sNS1 in the late endosomal compartment of hepatocytes potentializes subsequent dengue virus infection in vitro, raising the possibility that sNS1 may contribute to viral propagation in vivo.


Subject(s)
Viral Nonstructural Proteins/metabolism , Animals , Cytoplasm/metabolism , Dengue Virus/physiology , Endocytosis , Endosomes/metabolism , Hepatocytes/metabolism , Hepatocytes/virology , Humans , Injections, Intravenous , Liver/metabolism , Male , Mice , Time Factors , Viral Nonstructural Proteins/administration & dosage , Viral Nonstructural Proteins/isolation & purification , Virus Replication
16.
Nat Cell Biol ; 7(7): 653-64, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15951806

ABSTRACT

During viral infection, fusion of the viral envelope with endosomal membranes and nucleocapsid release were thought to be concomitant events. We show here that for the vesicular stomatitis virus they occur sequentially, at two successive steps of the endocytic pathway. Fusion already occurs in transport intermediates between early and late endosomes, presumably releasing the nucleocapsid within the lumen of intra-endosomal vesicles, where it remains hidden. Transport to late endosomes is then required for the nucleocapsid to be delivered to the cytoplasm. This last step, which initiates infection, depends on the late endosomal lipid lysobisphosphatidic acid (LBPA) and its putative effector Alix/AIP1, and is regulated by phosphatidylinositol-3-phosphate (PtdIns3P) signalling via the PtdIns3P-binding protein Snx16. We conclude that the nucleocapsid is exported into the cytoplasm after the back-fusion of internal vesicles with the limiting membrane of late endosomes, and that this process is controlled by the phospholipids LBPA and PtdIns3P and their effectors.


Subject(s)
Cytosol/metabolism , Endosomes/metabolism , Membrane Fusion/physiology , Nucleocapsid/metabolism , Animals , Biological Transport/physiology , Cattle , Cell Line , Cricetinae , Cytosol/ultrastructure , Endosomal Sorting Complexes Required for Transport , Endosomes/ultrastructure , Epithelial Cells/virology , Fibroblasts/virology , HeLa Cells , Humans , Lysophospholipids/physiology , Membrane Fusion/drug effects , Microscopy, Electron , Microscopy, Fluorescence , Monoglycerides , Phosphatidylinositol Phosphates/physiology , Phosphoproteins/genetics , Phosphoproteins/physiology , RNA, Viral/biosynthesis , RNA, Viral/metabolism , Signal Transduction/physiology , Sorting Nexins , Time Factors , Transport Vesicles/metabolism , Transport Vesicles/ultrastructure , Vesicular Transport Proteins/genetics , Vesicular Transport Proteins/physiology , Vesicular stomatitis Indiana virus/physiology , Virus Replication/genetics
17.
Arterioscler Thromb Vasc Biol ; 25(3): 639-45, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15618541

ABSTRACT

OBJECTIVE: Oxidized low-density lipoprotein (oxLDL)-induced apoptosis of vascular endothelial cells may contribute to plaque erosion and rupture. We aimed to clarify the relationship between the oxLDL-induced calcium signal and induction of apoptotic pathways. METHODS AND RESULTS: Apoptosis was evaluated by biochemical methods, including studies of enzyme activities, protein processing, release of proapoptotic factors, chromatin cleavage, and especially by morphological methods that evaluate apoptosis/necrosis by SYTO-13/propidium iodide fluorescent labeling. The oxLDL-induced sustained calcium rise activated 2 distinct calcium-dependent mitochondrial apoptotic pathways in human microvascular endothelial cells. OxLDLs induced calpain activation and subsequent Bid cleavage and cytochrome C release, which were blocked by calpeptin. Cyclosporin-A inhibited cytochrome C release, possibly by inhibiting the opening of the mitochondrial permeability transition pore (mPTP). Calcineurin, another cyclosporin-sensitive step, was not implicated, because oxLDLs inhibited calcineurin and FK-506 treatment was ineffective. Cytochrome C release in turn induced caspase-3 activation. In addition, oxLDLs triggered release and nuclear translocation of mitochondrial apoptosis-inducing factor through a mechanism dependent on calcium but independent of calpains, mPTP, and caspases. CONCLUSIONS: OxLDL-induced apoptosis involves 2 distinct calcium-dependent pathways, the first mediated by calpain/mPTP/cytochrome C/caspase-3 and the second mediated by apoptosis-inducing factor, which is cyclosporin-insensitive and caspase-independent.


Subject(s)
Apoptosis/physiology , Arteriosclerosis/metabolism , Calcium/metabolism , Endothelium, Vascular/cytology , Endothelium, Vascular/metabolism , Lipoproteins, LDL/metabolism , Mitochondria/metabolism , Apoptosis/drug effects , Apoptosis Inducing Factor , Arteriosclerosis/pathology , BH3 Interacting Domain Death Agonist Protein , Calpain/metabolism , Carrier Proteins/metabolism , Caspase 3 , Caspase Inhibitors , Caspases/metabolism , Cells, Cultured , Cyclosporine/pharmacology , Cysteine Proteinase Inhibitors/pharmacology , Cytochromes c/metabolism , Flavoproteins/metabolism , Humans , Immunosuppressive Agents/pharmacology , Membrane Proteins/metabolism , Microcirculation , Tacrolimus/pharmacology
18.
Curr Biol ; 14(15): 1397-404, 2004 Aug 10.
Article in English | MEDLINE | ID: mdl-15296759

ABSTRACT

Paramecium, like other ciliates, remodels its entire germline genome at each sexual generation to produce a somatic genome stripped of transposons and other multicopy elements. The germline chromosomes are fragmented by a DNA elimination process that targets heterochromatin to give a reproducible set of some 200 linear molecules 50 kb to 1 Mb in size. These chromosomes are maintained at a ploidy of 800n in the somatic macronucleus and assure all gene expression. We isolated and sequenced the largest megabase somatic chromosome in order to explore its organization and gene content. The AT-rich (72%) chromosome is compact, with very small introns (average size 25 nt), short intergenic regions (median size 202 nt), and a coding density of at least 74%, higher than that reported for budding yeast (70%) or any other free-living eukaryote. Similarity to known proteins could be detected for 57% of the 460 potential protein coding genes. Thirty-two of the proteins are shared with vertebrates but absent from yeast, consistent with the morphogenetic complexity of Paramecium, a long-standing model for differentiated functions shared with metazoans but often absent from simpler eukaryotes. Extrapolation to the whole genome suggests that Paramecium has at least 30,000 genes.


Subject(s)
Chromosomes/genetics , Genes, Protozoan/genetics , Genome, Protozoan , Paramecium tetraurelia/genetics , Animals , Base Composition , Base Sequence , Chromosome Mapping , Gene Components , Gene Library , Molecular Sequence Data , Open Reading Frames/genetics , Repetitive Sequences, Nucleic Acid/genetics , Sequence Analysis, DNA , Sequence Homology
19.
Science ; 303(5657): 531-4, 2004 Jan 23.
Article in English | MEDLINE | ID: mdl-14739459

ABSTRACT

What are the components that control the assembly of subcellular organelles in eukaryotic cells? Although membranes can clearly be distorted by cytosolic factors, very little is known about the intrinsic mechanisms that control the biogenesis, shape, and organization of organellar membranes. Here, we found that the unconventional phospholipid lysobisphosphatidic acid (LBPA) could induce the formation of multivesicular liposomes that resembled the multivesicular endosomes that exist where this lipid is found in vivo. This process depended on the same pH gradient that exists across endosome membranes in vivo and was selectively controlled by Alix. In turn, Alix regulated the organization of LBPA-containing endosomes in vivo.


Subject(s)
Calcium-Binding Proteins/metabolism , Carrier Proteins/metabolism , Endosomes/metabolism , Liposomes/metabolism , Lysophospholipids/metabolism , Animals , Annexin A2/metabolism , Arylsulfonates/metabolism , Calcium-Binding Proteins/genetics , Carrier Proteins/genetics , Cell Cycle Proteins , Cell Line , Coloring Agents/metabolism , Cytosol/metabolism , Endocytosis , Endosomal Sorting Complexes Required for Transport , Endosomes/ultrastructure , HeLa Cells , Humans , Hydrogen-Ion Concentration , Lipid Bilayers , Lysophospholipids/chemistry , Membrane Glycoproteins/metabolism , Molecular Structure , Monoglycerides , RNA Interference , RNA, Small Interfering/metabolism , Vesicular stomatitis Indiana virus/physiology , Viral Envelope Proteins/metabolism
20.
Mol Aspects Med ; 24(4-5): 251-61, 2003.
Article in English | MEDLINE | ID: mdl-12893003

ABSTRACT

Among the diverse risk factors involved in atherosclerosis, LDL are thought to become atherogenic after undergoing oxidative modifications, characterized by oxidized lipid formation and structural alterations of apoB. Oxidized LDL alter various signaling pathways and exhibit a broad range of biological responses including inflammation, gene expression, cell proliferation or apoptosis. The biological effects of oxidized LDL are related to the presence of peroxidation products such as hydroperoxides, lysophosphatidylcholines, oxysterols and aldehydes.4-Hydroxynonenal (HNE) is one of the most abundant aldehydes formed during the oxidation of polyunsaturated fatty acids in LDL and in membranes. It is able to react with thiols and free amino group residues of proteins. HNE is involved in apoB modifications that alter LDL metabolism and cell protein-adduct formation which may mediate in part the biological effects of oxidized LDL. We report here that HNE delivered to cells by oxidized LDL reacts with cellular proteins, for instance with tyrosine kinase receptors (RTK) such as EGFR and PDGFR. HNE induces in vitro derivatization and tyrosine phosphorylation of RTK (the fine molecular mechanism and conformational changes remain to be elucidated). In intact living cells, oxidized LDL (and pure HNE) trigger HNE-adduct formation and activation of PDGFR and EGFR, through an antioxidant-insensitive and reactive oxygen species independent mechanism. The presence of HNE-PDGFR adducts in atherosclerotic areas lead one to hypothesize that oxidized lipids may also react in vivo with membrane RTK, thereby disturbing their cellular functions.


Subject(s)
Aldehydes/metabolism , Cholesterol, LDL/metabolism , Receptor Protein-Tyrosine Kinases/metabolism , Animals , Arteriosclerosis/metabolism , Humans , Oxidation-Reduction , Signal Transduction/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...